Skip to content

Effect of Premeal Protein-bar on Food Intake

An Exploratory Study of the Effect of Premeal Consumption of Protein-enriched, Dietary Fiber-fortified Cereal Bar on Food Intake in Healthy Subjects

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03431233
Enrollment
20
Registered
2018-02-13
Start date
2017-08-01
Completion date
2019-06-01
Last updated
2019-08-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Subjects

Keywords

protein-enriched bar, food intake, appetite, satiety related hormones

Brief summary

The aim of this study is to explore premeal protein-enriched bar effect in food intake in healthy subjects.

Detailed description

Twenty healthy subjects will be recruited. Every subject will be randomized in 6 groups and studied on 3 separate days in random order with 1 week intervals. These participants will consume protein enriched bar, commercial cereal bar, or water followed by a standardized diet (gimbap). For study outcomes, food intake, appetite and satiety (visual analog scale), plasma glucose, and satiety related hormone will be measured. Blood sampling will be done before 15 min of breakeast, at the moment of start of breakfast (0 min), and then 30, 60, 90, 120 min. Plasma glucose levels, total/active GLP-1, ghrelin, total PYY will be measured.

Interventions

DIETARY_SUPPLEMENTProtein-enriched bar, commercial cereal bar, or water

Protein enriched bar, commercial cereal bar, or water will be provided 15 minutes before breakfast.

Sponsors

Seoul National University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
19 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Inclusion Criteria: * BMI 18.5\ 35 kg/m2 * Never diagnosed by diabetes * Fasting plasma glucose \<=100mg/dl and HbA1c \<6.0% *

Exclusion criteria

* Those who diagnosed by Type 1 or Type 2 diabetes * Allergy to wheat, flour, nuts, milk * Pregnancy/lactation * AST or ALT \>2.5 times of upper normal reference range * eGFR \<30 mL/min/1.73m2 * Hb \<10g/dl * History of GI surgery (except hemorrhoidectomy, appendectomy)

Design outcomes

Primary

MeasureTime frameDescription
Food intake120mingrams and caloric intake of standardized gimbap

Secondary

MeasureTime frameDescription
Satiety (visual analogue scale : score 1 to 10)120min
plasma glucose (mmol/L)-15min, 0(breakfast), 30, 60, 90, 120 minplasma level of glucose
Appetite (visual analogue scale : score 1 to 10)120min(1: I am not hungry at all, 10: I have never been more hungry)
plasma active ghrelin (ng/ml)-15min, 0(breakfast), 30, 60, 90, 120 minplasma level of active ghrelin
plasma total peptide YY (pg/ml)-15min, 0(breakfast), 30, 60, 90, 120 minplasma level of peptide YY
plasma active/total GLP-1 (pmol/L)-15min, 0(breakfast), 30, 60, 90, 120 minplasma level of active/total GLP-1

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026